A
GILD icon

Argentarii’s Gilead Sciences GILD Stock Holding History

Argentarii’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472K Buy
3,387
+35
+1% +$4.9K 0.17% 118
2025
Q4 		$411K Buy
3,352
+7
+0.2% +$851 0.13% 126
2025
Q3 		$371K Buy
3,345
+3
+0.1% +$341 0.15% 110
2025
Q2 		$371K Sell
3,342
-50
-1% -$5.32K 0.17% 105
2025
Q1 		$380K Buy
3,392
+99
+3% +$10.2K 0.19% 111
2024
Q4 		$304K Buy
+3,293
New +$296K 0.15% 113

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Argentarii's GILD Position: Q1 2026 in Review

Argentarii increased its Gilead Sciences (GILD) stake by 1% in Q1 2026, buying an estimated $4.9K and bringing the position to 3,387 shares worth $472K. The position accounts for 0.17% of the portfolio, ranked #118.

Argentarii first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Argentarii held 3,387 shares of Gilead Sciences worth $472K as of Q1 2026.
  • Argentarii bought 35 Gilead Sciences shares in Q1 2026, an estimated $4.9K.
  • Gilead Sciences made up 0.17% of Argentarii's portfolio in Q1 2026, its #118 holding.
  • Argentarii first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Argentarii's 13F filing for Q1 2026, filed 12 May 2026.